Page last updated: 2024-10-17

bupropion and Apraxias

bupropion has been researched along with Apraxias in 1 studies

Bupropion: A propiophenone-derived antidepressant and antismoking agent that inhibits the uptake of DOPAMINE.
bupropion : An aromatic ketone that is propiophenone carrying a tert-butylamino group at position 2 and a chloro substituent at position 3 on the phenyl ring.

Apraxias: A group of cognitive disorders characterized by the inability to perform previously learned skills that cannot be attributed to deficits of motor or sensory function. The two major subtypes of this condition are ideomotor (see APRAXIA, IDEOMOTOR) and ideational apraxia, which refers to loss of the ability to mentally formulate the processes involved with performing an action. For example, dressing apraxia may result from an inability to mentally formulate the act of placing clothes on the body. Apraxias are generally associated with lesions of the dominant PARIETAL LOBE and supramarginal gyrus. (From Adams et al., Principles of Neurology, 6th ed, pp56-7)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
De la Torre-Colmenero, JD1
Arjona-Padillo, A1
Fernandez-Perez, J1

Other Studies

1 other study available for bupropion and Apraxias

ArticleYear
[Reversible cerebral vasoconstriction syndrome following smoking cessation and treatment with bupropion].
    Revista de neurologia, 2018, May-01, Volume: 66, Issue:9

    Topics: Apraxias; Bupropion; Calcium Channel Blockers; Carotid Stenosis; Cerebral Arteries; Cerebrovascular

2018